Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mitogenic activity of Epstein–Barr virus-encoded BARF1 protein

Abstract

We previously reported that BARF1 gene has either an immortalizing effect, when expressed in primary primate epithelial cells, or a malignant transforming activity, when expressed in established and nontumoral rodent fibroblast or human B-cell lines. As predicted from sequence analysis, we found that BARF1 coded protein can be secreted from different cell lines, among them BARF1-transfected Balb/c3T3 rodent fibroblasts. Thus, as an initial step to clarify BARF1 oncogenic functions, we investigated whether the secreted form of BARF1 protein can activate the cell cycle as a growth factor. Since efficient BARF1 expression could be obtained from 293-tTA cells infected with a tetracycline-regulatable recombinant adenovirus, secreted BARF1 product could be purified from the culture medium of such cells by ammonium sulfate precipitation, ion exchange chromotography and sucrose gradient sedimentation. We describe in this paper that addition of a purified product of secreted BARF1 protein to serum-free culture medium of Balb/c3T3 rodent fibroblasts, human Louckes B-cell line and primary monkey kidney epithelial cells resulted in a cell cycle activation that was inhibited by affinity-purified anti-BARF1 antibody. Our demonstration of a specific stimulation of cell cycle in vitro by BARF1 secreted product suggests that this EBV-encoded BARF1 protein could act as a growth factor in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Cohen J and Lekstrom K . (1999). J. Virol., 73, 7627–7632.

  • Danve C, Decaussin G, Busson P and Ooka T . (2001). Virology, 288, 223–235.

  • Decaussin G, Sbih-Lammali F, De Turenne-Tessier M, Bouguermouh AM and Ooka T . (2000). Cancer Res., 60, 5584–5588.

  • Gao Y, Lu YJ, Xue SA, Chen H, Wedderburn N and Griffin BE . (2002). Oncogene, 21, 825–835.

  • Hayes DP, Brink AA, Vervoort MB, Middeldorp JM, Meijer CJ and van den Brule AJ . (1999). Mol. Pathol., 52, 97–103.

  • Karran L, Teo CG, King D, Hitt MM, Gao Y, Wedderburn N and Griffin BE . (1990). Int. J. Cancer, 45, 763–772.

  • Kieff E . (1996). Fields Virology, Fields BN, Knipe DM and Howley PM (eds.) 3rd edn. Lippincott-Raven Publishers: Philadelphia, PA (chapter 74), pp. 2343–2394.

    Google Scholar 

  • Massie B, Mosser DD, Koutroumanis M, Vitté-Mony I, Lamoureux L, Couture F, Paquet L, Guilbault C, Dionne J, Chahla D, Jolicoeur P and Langelier Y . (1998). Cytotechnology, 28, 53–64.

  • Nishikawa J, Imai S, Oda T, Kojima T, Okita K and Takada K . (1999). J. Virol., 73, 1286–1292.

  • Ooka T . (2001). EBV. Rep., 8, 177–182.

  • Rickinson AB and Kieff E . (2002). Fields Virology, Fields BN, Knipe DM and Howley PM (eds.), 4th edition Lippincott-Raven Publishers: Philadelphia, PA, pp. 257–2627.

    Google Scholar 

  • Sbih-Lammali F, Bouguermouh AM, Decaussin G and Ooka T . (1996). J. Med. Virol., 49, 7–14.

  • Sheng W, Decaussin G, Ligout A, Takada K and Ooka T . (2003). J. Virol., 77, 3859–3865.

  • Sheng W, Decaussin G, Sumner S and Ooka T . (2001). Oncogene, 20, 1176–1185.

  • Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF, Armitage RJ and Spriggs MK . (1998). J. Virol., 72, 4015–4021.

  • Tanner JE, Wei MX, Ahamad A, Alfieri C, Tailor P, Ooka T and Menezes J . (1997). J. Infect. Dis, 175, 38–46.

  • de Turenne-Tessier M, Jolicoeur P, Middeldorp J and Ooka T (Submitted).

  • Wei MX, de Turenne-Tessier M, Decaussin G, Benet G and Ooka T . (1997). Oncogene, 14, 3073–3082.

  • Wei MX, Moulin JC, Decaussin G, Berger F and Ooka T . (1994). Cancer Res., 54, 1843–1848.

  • Wei MX and Ooka T . (1989). EMBO J., 8, 2897–2903.

  • Xue SA, Labrecque LG, Lu QL, Ong SK, Lampert IA, Kazembe P, Molyneux E, Broadhead RL, Borgstein E and Griffin BE . (2002). Int. J. Cancer, 99, 635–643.

  • Zhang CX, Decaussin G, Finerty S, Morgan A and Ooka T . (1992). Virus Res., 26, 153–166.

  • Zur Hausen A, Brink AA, Craanen ME, Middeldorp J, Meijer CJ and van Den Brule AJ . (2000). Cancer Res., 60, 2745–2748.

Download references

Acknowledgements

This work was supported by Grants Nos. 4486 and 3381 from the ARC (Association pour la Recherche contre le Cancer) and Ligue National contre le Cancer (Comité du Rhône).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tadamasa Ooka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sall, A., Caserta, S., Jolicoeur, P. et al. Mitogenic activity of Epstein–Barr virus-encoded BARF1 protein. Oncogene 23, 4938–4944 (2004). https://doi.org/10.1038/sj.onc.1207607

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207607

Keywords

This article is cited by

Search

Quick links